You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Antimicrobial-releasing gels for preventing infection in total joint arthroplasty
SBC: SONORAN BIOSCIENCES INC Topic: NIAMSDESCRIPTION (provided by applicant): Orthopaedic Surgical Site Infections (SSIs), including Prosthetic Joint Infections (PJIs), are an extremely costly health care problem, illustrated by the 70,000- 114,000 average total cost per case to treat more than20,000 hip and knee replacement infections in the US each year. When a prosthetic joint becomes infected following arthroplasty, organisms form ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Decoy Peptides: Development of a Novel Therapeutic for Metastatic Cancer
SBC: ARIZONA CANCER THERAPEUTICS L.L.C. Topic: NCIDESCRIPTION (provided by applicant): Arizona Cancer Therapeutics LLC (ACT) proposes a two-year, preclinical research project in cooperation with the University of Arizona Cancer Center to develop the novel anti-tumor therapeutic, Protein transduction domain-MUC1 Inhibitory Peptide (PMIP). PMIP is an intracellular MUC1 peptide that acts as a decoy to block the MUC1- oncoprotein interactions that dr ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Slip-flow chromatography
SBC: BIOVIDRIA, INC. Topic: NIGMSDESCRIPTION: The product will be a packed capillary for nanoUHPLC of peptides that provides a dramatic increase in speed and efficiency. Current commercial columns for high speed and efficiency use sub-2 mm particles. The proposed technology uses sub-0.2mm particles. The ability to use such small particles for UHPLC is enabled by the phenomenon of slip flow, which gives enhanced volume flow rat ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Reduced gluten cereal grains
SBC: Arcadia Biosciences, Inc. Topic: NIDDKDESCRIPTION (provided by applicant): Celiac disease (CD) is the most common food sensitive enteropathy known, affecting approximately 1% of the population and its incidence appears to be on the rise. In addition, non-celiac gluten sensitivity (GS) has recently been revealed to be a distinct condition that affects a growing number of individuals. Both of these conditions are triggered by gluten, a ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Commercialization of a Diagnostic test for amyotrophic lateral sclerosis (ALS)
SBC: IRON HORSE DIAGNOSTICS, INC. Topic: NINDSDESCRIPTION (provided by applicant): Amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) is a fatal neurodegenerative disease with a typical lifespan of 3 - 5 years after diagnosis. The initial symptoms can be similar to many other neurologic disorders and often begin with limb weakness, muscle fasciculations, or increasing difficulties in speech or breathing. No definitive diagnostic ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Ultrasensitive Detection of Hepatitis Viruses by Immunoassay Amplification
SBC: BCR DIAGNOSTICS, INC. Topic: NIAIDDESCRIPTION (provided by applicant): This proposal responds to the action plan for combating the Silent Epidemic of Viral Hepatitis recently launched by the National Institutes of Health by focusing on early diagnosis of hepatitis, which is crucial for preventing further infections and to improve therapy. Approximately 170 million people are infected with HCV, many of whom develop cirrhosis and l ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Tissue iron measurement by MRI: a new approach to analysis, training and certific
SBC: DMetrix, Inc Topic: NIDCRDESCRIPTION (provided by applicant): The ability to accurately detect the developing lesions at early stage in dental practice and to quantify the lesions will provide dentists with the opportunity of initiating early prophylactic treatment; correct diagnosis of a fractured tooth in is earliest possible stage encourages more conservative treatment options as well as an improved prognosis. We propo ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Inhibitors of Mycobacterial Protein Tyrosine Phosphatase B (mPTPB) for therapy of
SBC: INXSOL LLC Topic: NIEHSDESCRIPTION (provided by applicant): ExposureTrack is an innovative and necessary service that will support the at-risk worker population. inXsol LLC (inXsol) proposed to prototype, demonstrate and evaluate ExposureTrack as a smart phone-based tool equipping individual response workers with a personal health monitoring and surveillance service. For this project inXsol will: 1) assemble and dem ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Alternative Pathway Inhibitors for Orphan Indication
SBC: BIOSENSING INSTRUMENT INC Topic: NIGMSDESCRIPTION (provided by applicant): We are proposing a technology to help in three key areas of proteomics including (a) recognition of protein interactions, (b) characterization of post translational modifications, and (c) quantitative measurements athigh spatial and/or temporal resolution to address the dynamics of protein interactions. Several significant types of protein interactions remain ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Discovery of T-type Calcium Channel Antagonists from Multicomponent Reactions and Their Application in Paclitaxel-induced Peripheral Neuropathy
SBC: Regulonix Topic: 101Summary Abstract Chemotherapy induced peripheral neuropathyCIPNis detected inof cancer patients during all phases of cancerSensory symptoms in the hands and or feettypically in astocking glovepatternare commonand manifested as painnumbnessand or tinglingCIPN can result in chemotherapy dose reduction or discontinuationand can also have long term effects on the quality of lifeThe course of CIPN can ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health